JAMA (Journal of the American Medical Association)
Open in Telegram
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Show more📈 Analytical overview of Telegram channel JAMA (Journal of the American Medical Association)
Channel JAMA (Journal of the American Medical Association) (@jamaupdates) in the English language segment is an active participant. Currently, the community unites 15 827 subscribers, ranking 1 534 in the Medicine category and 2 414 in the USA region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 15 827 subscribers.
According to the latest data from 26 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 447 over the last 30 days and by 33 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 7.02%. Within the first 24 hours after publication, content typically collects 2.38% reactions from the total number of subscribers.
- Post reach: On average, each post receives 1 111 views. Within the first day, a publication typically gains 376 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
- Thematic interests: Content is focused on key topics such as patient, disease, treatment, drug, guideline.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“All the latest articles published on JAMA before going in to print
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot”
Thanks to the high frequency of updates (latest data received on 27 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
15 827
Subscribers
+3324 hours
+1197 days
+44730 days
Data loading in progress...
Similar Channels
Tags Cloud
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
July '26
July '26
+396
in 0 channels
June '26
+422
in 0 channels
Get PRO
May '26
+584
in 0 channels
Get PRO
April '26
+437
in 0 channels
Get PRO
March '26
+217
in 0 channels
Get PRO
February '26
+247
in 0 channels
Get PRO
January '26
+321
in 0 channels
Get PRO
December '25
+277
in 0 channels
Get PRO
November '25
+366
in 2 channels
Get PRO
October '25
+164
in 0 channels
Get PRO
September '25
+12
in 0 channels
Get PRO
August '25
+29
in 0 channels
Get PRO
July '25
+30
in 0 channels
Get PRO
June '25
+17
in 0 channels
Get PRO
May '25
+9
in 0 channels
Get PRO
April '25
+5
in 0 channels
Get PRO
March '25
+17
in 0 channels
Get PRO
February '25
+12
in 0 channels
Get PRO
January '25
+18
in 1 channels
Get PRO
December '24
+237
in 0 channels
Get PRO
November '24
+1 122
in 0 channels
Get PRO
October '24
+1 120
in 0 channels
Get PRO
September '24
+1 527
in 1 channels
Get PRO
August '24
+1 128
in 1 channels
Get PRO
July '24
+1 216
in 0 channels
Get PRO
June '24
+781
in 1 channels
Get PRO
May '24
+797
in 1 channels
Get PRO
April '24
+808
in 1 channels
Get PRO
March '24
+821
in 2 channels
Get PRO
February '24
+753
in 1 channels
Get PRO
January '24
+768
in 0 channels
Get PRO
December '23
+716
in 1 channels
Get PRO
November '23
+96
in 1 channels
Get PRO
October '23
+86
in 0 channels
Get PRO
September '23
+73
in 0 channels
Get PRO
August '23
+90
in 0 channels
Get PRO
July '23
+107
in 0 channels
Get PRO
June '23
+105
in 0 channels
Get PRO
May '23
+169
in 0 channels
Get PRO
April '23
+128
in 0 channels
Get PRO
March '23
+84
in 0 channels
Get PRO
February '23
+75
in 0 channels
Get PRO
January '23
+71
in 0 channels
Get PRO
December '22
+74
in 0 channels
Get PRO
November '22
+149
in 0 channels
Get PRO
October '22
+90
in 0 channels
Get PRO
September '22
+138
in 0 channels
Get PRO
August '22
+77
in 0 channels
Get PRO
July '22
+50
in 0 channels
Get PRO
June '22
+96
in 0 channels
Get PRO
May '22
+75
in 0 channels
Get PRO
April '22
+80
in 0 channels
Get PRO
March '22
+65
in 0 channels
Get PRO
February '22
+26
in 0 channels
Get PRO
January '22
+56
in 0 channels
Get PRO
December '21
+44
in 0 channels
Get PRO
November '21
+39
in 0 channels
Get PRO
October '21
+61
in 0 channels
Get PRO
September '21
+66
in 0 channels
Get PRO
August '21
+65
in 0 channels
Get PRO
July '21
+96
in 0 channels
Get PRO
June '21
+120
in 0 channels
Get PRO
May '21
+130
in 0 channels
Get PRO
April '21
+812
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 27 July | +4 | |||
| 26 July | +33 | |||
| 25 July | +10 | |||
| 24 July | +14 | |||
| 23 July | +20 | |||
| 22 July | +7 | |||
| 21 July | +36 | |||
| 20 July | 0 | |||
| 19 July | +5 | |||
| 18 July | +9 | |||
| 17 July | +20 | |||
| 16 July | +26 | |||
| 15 July | +6 | |||
| 14 July | +11 | |||
| 13 July | +15 | |||
| 12 July | +12 | |||
| 11 July | +17 | |||
| 10 July | +22 | |||
| 09 July | +6 | |||
| 08 July | +5 | |||
| 07 July | +18 | |||
| 06 July | +20 | |||
| 05 July | +13 | |||
| 04 July | +20 | |||
| 03 July | +14 | |||
| 02 July | +19 | |||
| 01 July | +14 |
Channel Posts
Exercise and Aortic Stenosis
https://jamanetwork.com/journals/jamacardiology/fullarticle/2851755
The management of severe aortic stenosis (AS) is undergoing a fundamental transformation. For decades, intervention was generally deferred until symptom onset or overt left ventricular systolic dysfunction. This strategy reflected a rational clinical balance: procedural risk was substantial, symptom development signaled clinical decompensation, and watchful waiting appeared prudent. Today, that paradigm is increasingly challenged.
| 2 | Road Traffic Noise and Risk of Parkinson Disease
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851756
This cohort study evaluates the association between long-term exposure to road traffic noise and risk of Parkinson disease. | 1 051 |
| 3 | Error in Text
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851758
In the Images in Neurology titled “Aberrant Left-to-Right Fusion of the Oculomotor Nerve,” published on May 26, 2026, there was an error in the units of measure provided in the second sentence of the first paragraph. The sentence should have read, “On examination, the patient’s primary position revealed a 20° esotropia of the right eye and a 25° exotropia of the left eye, accompanied by mild ptosis and notable enophthalmos.” This article was corrected online. | 994 |
| 4 | Environmental Risk in Parkinson Disease—Bring the Noise
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851757
Parkinson disease (PD) affects over 11 million people worldwide and is among the fastest-growing causes of neurological death and disability. This trend highlights the critical need to identify and address modifiable risk factors of PD. Several environmental chemicals have been linked to PD risk, including pesticides, hydrocarbon solvents, and air pollutants. Living in areas with increased potential exposure to environmental toxicants—including farms, industrial sites, and golf courses—is also associated with PD. Given this mounting evidence, strategies to reduce the global burden of PD must focus on environmental risk factors. | 847 |
| 5 | Error in the Strengths and Limitations
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851759
In the Original Investigation titled “Amateur Soccer Heading and Acute Elevations in Blood-Based p-Tau217 and S100B,” published online on May 18, 2026, there was an error in the Strengths and Limitations section regarding a biomarker referred to as being lower in the exposed group. Biomarkers “S100B and NfL” have been changed to “S100B and BD-tau.” This article has been corrected online. | 710 |
| 6 | Clear Liquids, Safer Procedures
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851435
To the Editor We read with interest the OCULUS randomized clinical trial by Ahmad and colleagues that evaluated the effects of continuing vs withholding glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (GLP-1/GIP RAs) before upper endoscopy. As the first such trial to our knowledge, it addressed a gap in evidence regarding periprocedural management of these agents, which has previously been guided mainly by observational data and expert opinion. | 643 |
| 7 | Practice Pattern and Outcome Differences in the ED by Physician Sex
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851436
This cross-sectional study evaluates differences in test ordering and hospital admission rates between female and male physicians working in the Veterans Affairs system’s emergency departments. | 529 |
| 8 | From Initiation of Guideline-Directed Medical Therapy to Persistent Use in Heart Failure
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851437
Clinical guidelines recommend that patients with heart failure with reduced ejection fraction (HFrEF) should be treated with 4 classes of medications: renin-angiotensin system inhibitors, β-blockers, mineralocorticoid receptor antagonists, and sodium-glucose co-transporter 2 inhibitors. Guideline-directed medical therapy (GDMT) is associated with improved survival and reduction in hospitalizations for heart failure and incremental benefit is observed with use of all 4 classes of drugs. | 525 |
| 9 | Clinician Moral Injury and Immigration Policy
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851438
Since January 2025, this country has undertaken what is likely among the most expansive immigration enforcement agendas in modern US history. Immigration policy has focused on aggressive enforcement tactics rather than integration and immigrant well-being. This policy agenda and its enforcement have resulted in fear, isolation, and decreased health care utilization among those with immigrant backgrounds. Additionally, the provision of health care has been affected by policies allowing Immigration and Customs Enforcement (ICE) agents to enter previously protected locations including hospitals, and sharing data between the Centers for Medicare & Medicaid Services and Department of Homeland Security. A less well-known effect of the increased immigration enforcement is the harm experienced by those clinicians caring for immigrant populations, through moral injury and vicarious traumatization. This issue of JAMA Internal Medicine includes 2 articles exploring the moral injury experienced by clinicians caring for immigrant patients in the US during the recent, and ongoing, surge of immigration law enforcement action. | 499 |
| 10 | Physician Sex and Practice Pattern Differences in the Emergency Department
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851439
There is a growing literature on physician sex differences in patient care and outcomes that largely favor female physicians. Studies in the primary care setting find, for example, that female physicians spend more time in direct and indirect patient care, use more patient-centered communication, and provide more evidence-based services, although the evidence is more mixed on the provision of low-value care. But one challenge of these studies is that it is difficult in the primary care setting to disentangle the effects of patient expectations, self-selection to their treating physician, and the dyadic interaction between patient and clinician on practice patterns and outcomes. Hospital-based studies that can leverage more random assignment of patients to physicians have found that patients treated by female physicians have better outcomes, such as lower mortality and hospital readmission rates, but beyond this, little is understood about how practice patterns differ by sex in the acute care setting. | 599 |
| 11 | Cessation of Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis—Clinical Trial of the Year
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851873
Can patients with multiple sclerosis (MS) safely discontinue their disease-modifying therapy, even after years of clinical stability? That is the question that was addressed by the DOT-MS trial, which is my pick for trial of the year in 2025. | 1 183 |
| 12 | Challenges Implementing Remote Patient Monitoring for Hypertension
https://jamanetwork.com/journals/jamacardiology/fullarticle/2851053
The recent article by Unlu et al highlights persistent patient engagement barriers to effective hypertension management. Unfortunately, their concerns on home blood pressure monitoring (HBPM) miss a critical opportunity to highlight potential for mitigating serious morbidity and mortality in a particular patient subgroup: pregnancy. | 1 135 |
| 13 | Device-Assisted and Modified Valsalva Maneuvers for Supraventricular Tachycardia
https://jamanetwork.com/journals/jamacardiology/fullarticle/2851054
To the Editor We read with great interest the Brief Report published by Huang et al, evaluating the performance of a device-assisted Valsalva maneuver compared with the standard maneuver for conversion of supraventricular tachycardia (SVT). | 1 098 |
| 14 | Reigniting the Effort to Prevent Premature Death and Extend Healthy Life Span
https://jamanetwork.com/journals/jamacardiology/fullarticle/2851055
This issue of JAMA Cardiology includes the latest of many substantial reports from the Global Burden of Disease Study regarding the trajectory of chronic disease in the US. The report’s overall storyline is not surprising: the underlying major risk factors for ischemic heart disease (IHD) are well known, and overall IHD mortality rates continue to drop. Reductions in risk due to improvements in blood pressure control and management of low-density lipoprotein (LDL) cholesterol levels likely explain much of the reduction in IHD risk since 1990. However, the rate of decrease has slowed since 2010, treatment effectiveness has plateaued, and progress remains inadequate. | 1 015 |
| 15 | Neurological Manifestations of Hantavirus Infection
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851731
This narrative review discusses the neurological complications of hantaviruses that, although rare, carry a high mortality rate, are typically secondary to ischemic injury or metabolic dysfunction, and can affect the peripheral or central nervous system. | 984 |
| 16 | Recommendations for Reporting on Potential Harms in Randomized Clinical Trials in JAMA Internal Medicine
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851381
Randomized clinical trials, when rigorously conducted, offer the highest level of evidence to evaluate health care interventions. The value of a health care intervention depends on the benefits relative to the harms, which can be physical, psychological, or social. Published reports of randomized clinical trials uniformly focus on the benefits of the intervention being studied but often provide inadequate information regarding harms. There have been documented failures to report serious adverse events related to interventions, as well as discrepancies in harms reporting that arise from different approaches to monitoring, collecting, and classifying adverse events. Beyond these notable failures, there has been a general lack of adequate information on methods, analyses, and outcomes related to harms of interventions. As a result, there is a well-recognized need to improve reporting of harms in randomized clinical trials. The Consolidated Standards of Reporting Trials (CONSORT) Harms 2022 guideline provides standards for reporting harms, and select items related to harms were included in the revision of the main CONSORT 2025 guideline on reporting clinical trials. In this Editorial, we outline 3 key expectations for reporting harms in randomized clinical trials published in JAMA Internal Medicine. | 1 199 |
| 17 | Dementia Prevalence Trends in Latin America and the Caribbean
https://jamanetwork.com/journals/jamaneurology/fullarticle/2851645
This cross-sectional study examines trends in dementia prevalence over 2 decades at 5 sites across Latin America and the Caribbean. | 1 034 |
| 18 | Hantavirus on a Nature Cruise and the Risk of a Pandemic
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2851366
This Viewpoint discusses the alarm surrounding the hantavirus cases first reported in May 2026 and burgeoning threats, such as Ebola virus. | 1 523 |
| 19 | Interpreting the APERITIF Randomized Clinical Trial—Reply
https://jamanetwork.com/journals/jamacardiology/fullarticle/2851275
In Reply Chen and Xiong raise important points. Given the open-label design of the trial, the selection of antiplatelet therapy was not random. As suggested, we analyzed the prevalence of left ventricular (LV) thrombus, maximal thrombus diameter, and Bleeding Academic Research Consortium (BARC) type 1 bleeding at 1 month according to the antithrombotic regimen at hospital discharge (Table). Discontinuation of antithrombotic therapy is reported in Supplement 3. | 1 591 |
| 20 | Interpreting the APERITIF Randomized Clinical Trial
https://jamanetwork.com/journals/jamacardiology/fullarticle/2851276
To the Editor Puymirat and colleagues report the APERITIF randomized clinical trial evaluating rivaroxaban, 2.5 mg, twice daily for 4 weeks added to dual antiplatelet therapy (DAPT) to prevent left ventricular (LV) thrombus after anterior ST-segment elevation myocardial infarction (STEMI). The primary end point—LV thrombus on contrast-enhanced cardiac magnetic resonance (CMR) at 1 month—was neutral, while minor bleeding (Bleeding Academic Research Consortium [BARC] type 1) was increased in the rivaroxaban group. | 1 375 |
